MPND Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-79263
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
1 mg/ml
Product Specifications
Immunogen
Synthetic peptide directed towards the N terminal of human MPNDThe immunogen for this antibody is MPND. Peptide sequence MAAPEPLSPAGGAGEEAPEEDEDEAEAEDPERPNAGAGGGRSGGGGSSVS. The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Description
The addition of 50% glycerol is optional for those storing this antibody at -20C and not aliquoting smaller units. However, please note that glycerol may interrupt some downstream antibody applications and should be added with caution.
Scientific Data Images for MPND Antibody
![Western Blot: MPND Antibody [NBP1-79263]](https://resources.bio-techne.com/images/products/MPND-Antibody-Western-Blot-NBP1-79263-img0003.jpg "Western Blot: MPND Antibody [NBP1-79263]")
Western Blot: MPND Antibody [NBP1-79263]
Western Blot: MPND Antibody [NBP1-79263] - Titration: 2.5ug/ml Positive Control: HepG2 cell lysate.Applications for MPND Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
1 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: MPND
Alternate Names
EC 3.4, FLJ14981, MPN domain containing, MPN domain-containing protein
Gene Symbol
MPND
UniProt
Additional MPND Products
Product Documents for MPND Antibody
Product Specific Notices for MPND Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...